Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.940
-0.010 (-0.51%)
Jun 6, 2025, 2:45 PM CST

Kangmei Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
9.618.57102.52-2,6887,918-31,085
Upgrade
Depreciation & Amortization
334.57334.57346.18365.69603.22644.83
Upgrade
Other Amortization
38.8338.8322.4927.7335.19133.15
Upgrade
Loss (Gain) From Sale of Assets
-39.47-39.47-19.61-0.98-64.0144.96
Upgrade
Asset Writedown & Restructuring Costs
31.4731.4799.97307.462,6431,508
Upgrade
Loss (Gain) From Sale of Investments
-59.18-59.18-44.4-0.75-188.794.59
Upgrade
Provision & Write-off of Bad Debts
24.8924.89-238.47213.411,1921,003
Upgrade
Other Operating Activities
344.9114.76196.51278.142,57726,027
Upgrade
Change in Accounts Receivable
-502.64-502.64215.15-339.53-746.883,130
Upgrade
Change in Inventory
-34.32-34.32-93.01-253.621,6661,912
Upgrade
Change in Accounts Payable
-347.41-347.41-896.421,321-15,587-2,298
Upgrade
Change in Other Net Operating Assets
----0.59-8.93
Upgrade
Operating Cash Flow
-196.46-427.63-317.52-749.96214.211,031
Upgrade
Operating Cash Flow Growth
-----79.23%-64.21%
Upgrade
Capital Expenditures
-54.58-61.71-99.74-48.12-171.63-301.73
Upgrade
Sale of Property, Plant & Equipment
129.7164.3352.251.5577.91,135
Upgrade
Divestitures
19.827.39.85-57.72-0.74
Upgrade
Investment in Securities
-----0.53-
Upgrade
Other Investing Activities
1010-0.550.04-
Upgrade
Investing Cash Flow
104.92139.92-37.64-46.02-36.51832.06
Upgrade
Short-Term Debt Issued
----127.64-
Upgrade
Long-Term Debt Issued
-0.1---10,572
Upgrade
Total Debt Issued
0.10.1--127.6410,572
Upgrade
Short-Term Debt Repaid
-----97.03-
Upgrade
Long-Term Debt Repaid
--54.46-72.71-94.95-48.66-11,419
Upgrade
Total Debt Repaid
-54.46-54.46-72.71-94.95-145.69-11,419
Upgrade
Net Debt Issued (Repaid)
-54.36-54.36-72.71-94.95-18.05-847.07
Upgrade
Issuance of Common Stock
1.151.15--1,800-
Upgrade
Common Dividends Paid
-0.75-0.75--0.9-13.82-1,032
Upgrade
Dividends Paid
-0.75-0.75--0.9-13.82-1,032
Upgrade
Other Financing Activities
275.56228.78-48.14-21.010.252.77
Upgrade
Financing Cash Flow
221.59174.81-120.85-116.861,768-1,876
Upgrade
Foreign Exchange Rate Adjustments
-0-000-0.04-0.25
Upgrade
Net Cash Flow
130.05-112.91-476.01-912.841,946-13.13
Upgrade
Free Cash Flow
-251.04-489.34-417.27-798.0842.58729.67
Upgrade
Free Cash Flow Growth
-----94.16%-69.71%
Upgrade
Free Cash Flow Margin
-4.75%-9.43%-8.56%-19.09%1.03%13.48%
Upgrade
Free Cash Flow Per Share
-0.02-0.03-0.04-0.060.000.05
Upgrade
Cash Interest Paid
---1.06--
Upgrade
Cash Income Tax Paid
139.19295.28211.36284.45235.31295.57
Upgrade
Levered Free Cash Flow
1,396-313.11,126117.24-6,02921,968
Upgrade
Unlevered Free Cash Flow
1,408-299.731,161166.55-5,39123,320
Upgrade
Change in Net Working Capital
-1,309352.97-779.87-471.463,953-39,589
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.